Plazma D-Dimer Düzeyinin Yüksek Dereceli Seröz Over Kanseri Olan Olgularda Prognostik Verilerle Olan İlişkisi

Over kanseri jinekolojik kanserler arasında kansere bağlı ölümlerin önde gelen nedenidir. Kanser hastalarında özellikle ileri evrede, venöz tromboembolizm yokken bile hemostatik aktivasyona bağlı hiperkoagülasyon ve artmış fibrinoliz sıklıkla gözlenir. Bu çalışma ile yüksek dereceli seröz karsinom olgularında operasyon öncesi ölçülen plazma d-dimer düzeyinin klinik önemi ve prognostik değerini incelemeyi amaçladık. Retrosptektif olarak yapılan çalışmamızda Dr. Zekai Tahir Burak Eğitim ve Araştırma Hastanesi Jinekolojik Onkoloji Kliniği’nde 2013-2017 tarihleri arasında primer yüksek dereceli seröz over kanseri (HGSK) tanısı alan ve operasyondan önceki 15 gün içinde D-dimer testi yapılan 142 hasta dahil edildi. Tanı anındaki yaş, tedavi öncesi plazma D-dimer düzeyi, asit varlığı, rezidüel tümör, CA125 seviyesi, FIGO evresi ve demografik bilgileri karşılaştırıldı. Ortalama yaşları 55.25 ±10.84 olan hastaların 52’ sinde (%36,6) normal, 90’ ında(%63,4) D-dimer seviyeleri yüksek olarak saptandı. D-dimer düzeyi yüksek olan ve olmayan olgularda 60 yaş sınır alındığında anlamlı farklılık saptanmazken, D-dimer düzeyi yüksek olan olgularda FIGO evresi (III-IV) daha yüksek olup (p

The Relationship between Plasma D-Dimer Level and Prognostic Factors in Cases with High-Grade Serous Ovarian Cancer

Ovarian cancer is the leading cause of cancer-related death among gynecological cancers. Hypercoagulation and fibrinolysis increase due to hemostatic activation are frequently observed in advanced stages. We aimed to examine the clinical prognostic value of plasma D-dimer levels measured before the operation in high-stage serous ovarian cancer cases. We conducted a retrospective analysis of 142 patients who had diagnosed with high-grade serous ovarian cancer (HGSC) between 2013-2017 at the Gynecological Oncology Clinic of Dr.Zekai Tahir Burak Training Hospital. Age at diagnosis, pre-treatment plasma D-dimer level, presence of ascites, residual tumor, CA125 level, FIGO stage, and other demographic information were obtained. The mean patient age was 55.25 ±10.84 year. The D-dimer level was normal in 52 (%36,6) patients and high in 90(%63,4) patients. While there was no significant difference when the age limit of 60 was taken in cases with and without high D-dimer levels. Patients with FIGO stage(III-IV) was higher in cases with high D-dimer levels(p

___

  • 1. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D. and Bray, F. (2015). “Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012.” International Journal of Cancer, 136(5), E359-86. https://doi.org/10.1002/ijc.29210
  • 2. Kurman, R. J. and Shih, I.-M. (2016). “The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.” The American Journal of Pathology, 186(4), 733–747. https://doi.org/10.1016/j.ajpath.2015. 11.011
  • 3. Koshiyama, M., Matsumura, N. and Konishi, I. (2017). “Subtypes of Ovarian Cancer and Ovarian Cancer Screening.” Diagnostics (Basel, Switzerland), 7(1), 1-5. https://doi.org/10.3390/diagnostics7010012
  • 4. Cooke, S. L., & Brenton, J. D. (2011). “Evolution of platinum resistance in high-grade serous ovarian cancer”. The Lancet. Oncology, 12(12), 1169–1174. https://doi.org/10.1016/S1470-2045(11)70123-1
  • 5. Ogata, Y., Heppelmann, C. J., Heppelmann, C. J., Charlesworth, M. C., Madden, B. J., Miller, M. N., Kalli, K. R., Cliby, W. A., Bergen, H. R., Saggese, D. A. and Muddiman, D. C. (2006). “Elevated Levels of Phosphorylated Fibrinogen-Alpha-Isoforms and Differential Expression of Other Post-Translationally Modified Proteins in The Plasma of Ovarian Cancer Patients.” Journal of Proteome Research, 5(12), 3318-3325. https://doi.org/10.1021/pr060344+
  • 6. Ogata, Y., Heppelmann, C. J., Heppelmann, C. J., Charlesworth, M. C., Madden, B. J., Miller, M. N., Kalli, K. R., Cliby, W. A., Bergen, H. R., Saggese, D. A. and Muddiman, D. C. (2006). “Elevated Levels of Phosphorylated Fibrinogen-Alpha-Isoforms and Differential Expression of Other Post-Translationally Modified Proteins in The Plasma of Ovarian Cancer Patients.” Journal of Proteome Research, 5(12), 3318-3325. https://doi.org/10.1021/pr060344+
  • 7. Miralles, C., Orea, M., España, P., Provencio, M., Sánchez, A., Cantos, B., Cubedo, R., Carcereny, E., Bonilla, F. and Gea, T. (2003). “Cancer Antigen 125 Associated with Multiple Benign and Malignant Pathologies.” Annals of Surgical Oncology, 10(2), 150–154. https://doi.org/10.1245/aso.2003.05.015
  • 8. Sakurai, M., Matsumoto, K., Gosho, M., Sakata, A., Hosokawa, Y., Tenjimbayashi, Y., Katoh, T., Shikama, A., Komiya, H., Michikami, H., Tasaka, N., Akiyama-Abe, A., Nakao, S., Ochi, H., Onuki, M., Minaguchi, T., Yoshikawa, H. and Satoh, T. (2017). “Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 27(1), 37-43. https://doi.org/10.1097/IGC.0000000000000848
  • 9. Varol A, Köktürk N, Kılıç H, Aydoğdu M, Ekim NN. (2012). “The Role of Quantitative D-Dimer Levels in The Follow-Up and Differential Diagnosis of Pulmonary Thromboembolism and Community- Acquired Pneumonia.” Turk J Med Sci, 42, 639-47.
  • 10. Lin, Y., Liu, Z., Qiu, Y., Zhang, J., Wu, H., Liang, R., Chen, G., Qin, G., Li, Y. and Zou, D. (2018). “Clinical Significance of Plasma D-Dimer And Fibrinogen in Digestive Cancer: A Systematic Review and Meta-Analysis.” European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 44(10), 1494-1503. https://doi.org/10.1016/j.ejso.2018.07.052
  • 11. Zhu, L, Liu, B., Zhao, Y., Liu, L., Yang, C., Yang, Y. and Zhong, H. (2014). “High Levels of D-Dimer Correlated with Disease Status and Poor Prognosis of Inoperable Metastatic Colorectal Cancer Patients Treated with Bevacizumab.” J Cancer Res Ther, 10, 246-51.
  • 12. Chen, L., Wang, X., Shu, J., Xu, S., Wu, Q. and Yu, Y. (2019). “Diagnostic Value of Serum D-Dimer, CA125, and Neutrophil-To-Lymphocyte Ratio in Differentiating Ovarian Cancer and Endometriosis.” International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 147(2), 212–218. https://doi.org/10.1002/ijgo.12949
  • 13. Sakurai, M., Satoh, T., Matsumoto, K., Michikami, H., Nakamura, Y., Nakao, S., Ochi, H., Onuki, M., Minaguchi, T. and Yoshikawa, H. (2015). “High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 25(4), 593-598. https://doi.org/10.1097/IGC.0000000000000415.
  • 14. Kawaguchi, R., Furukawa, N. and Kobayashi, H. (2012). “Cut-off Value of D-Dimer for Prediction of Deep Venous Thrombosis Before Treatment in Ovarian Cancer.” Journal of Gynecologic Oncology, 23(2), 98-102. https://doi.org/10.3802/jgo.2012.23.2.98
  • 15. Liu, P., Wang, Y., Tong, L., Xu, Y., Zhang, W., Guo, Z. and Ni, H. (2015). “Elevated Preoperative Plasma D-Dimer Level is A Useful Predictor of Chemoresistance and Poor Disease Outcome for Serous Ovarian Cancer Patients.” Cancer Chemotherapy and Pharmacology, 76(6), 1163-1171. https://doi.org/10.1007/s00280-015-2900-y
  • 16. Khorana, A. A. and Fine, R. L. (2004). “Pancreatic Cancer and Thromboembolic Disease.” The Lancet. Oncology, 5(11), 655–663. https://doi.org/10.1016/ S1470-2045(04)01606-7
  • 17. Koldas, M., Gummus, M., Seker, M., Seval, H., Hulya, K., Dane, F., Kural, A., Gumus, A., Salepci, T. and Turhal, N. S. (2008). “Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Non-Small-Cell Lung Cancer.” Clinical Lung Cancer, 9(2), 112-115. https://doi.org/10.3816/clc.2008.n.017
  • 18. Kawai, K. and Watanabe, T. (2014). “Colorectal Cancer And Hypercoagulability.” Surgery Today, 44(5), 797-803. https://doi.org/10.1007/s00595-013-0606-5
  • 19. Tsimafeyeu, I. V, Demidov, L. V, Madzhuga, A. V, Somonova, O. V. and Yelizarova, A. L. (2009). “Hypercoagulability As A Prognostic Factor For Survival in Patients with Metastatic Renal Cell Carcinoma.” Journal of Experimental & Clinical Cancer Research : CR, 28, 30. https://doi.org/10.1186/1756-9966-28-30
  • 20. Altiay, G., Ciftci, A., Demir, M., Kocak, Z., Sut, N., Tabakoglu, E., Hatipoglu, O. N. and Caglar, T. (2007). “High Plasma D-Dimer Level is Associated with Decreased Survival in Patients with Lung Cancer.” Clinical Oncology (Royal College of Radiologists (Great Britain)), 19(7), 494–498. https://doi.org/10.1016/j.clon. 2007.04.002
  • 21. Dirix, L. Y., Salgado, R., Weytjens, R., Colpaert, C., Benoy, I., Huget, P., van Dam, P., Prové, A., Lemmens, J. and Vermeulen, P. (2002). “Plasma Fibrin D-Dimer Levels Correlate with Tumour Volume, Progression Rate and Survival in Patients With Metastatic Breast Cancer.” British Journal of Cancer, 86(3), 389-395. https://doi.org/10.1038/sj.bjc.6600069
  • 22. Ay, C., Dunkler, D., Pirker, R., Thaler, J., Quehenberger, P., Wagner, O., Zielinski, C. and Pabinger, I. (2012). “High D-Dimer Levels Are Associated with Poor Prognosis in Cancer Patients.” Haematologica, 97(8), 1158–1164. https://doi.org/10.3324/haematol.2011.054718
  • 23. Im, J. H., Fu, W., Wang, H., Bhatia, S. K., Hammer, D. A., Kowalska, M. A. and Muschel, R. J. (2004). “Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation.” Cancer Research, 64(23), 8613-8619. https://doi.org/10.1158/0008-5472.CAN-04-2078
  • 24. Caine, G. J., Stonelake, P. S., Lip, G. Y. H. and Kehoe, S. T. (n.d.). “The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate.” Neoplasia (New York, N.Y.), 4(6), 465-473. https://doi.org/10.1038/sj.neo. 7900263
  • 25. Bluff, J. E., Brown, N. J., Reed, M. W. R. and Staton, C. A. (2008). “Tissue Factor, Angiogenesis and Tumour Progression.” Breast Cancer Research : BCR, 10(2), 204. https://doi.org/10.1186/bcr1871
  • 26. Dirix, L. Y., Salgado, R., Weytjens, R., Colpaert, C., Benoy, I., Huget, P., van Dam, P., Prové, A., Lemmens, J. and Vermeulen, P. (2002). “Plasma Fibrin D-Dimer Levels Correlate with Tumour Volume, Progression Rate and Survival in Patients With Metastatic Breast Cancer.” British Journal of Cancer, 86(3), 389-395. https://doi.org/10.1038/sj.bjc.6600069
  • 27. Wu, J., Fu, Z., Liu, G., Xu, P., Xu, J. and Jia, X. (2017). “Clinical Significance of Plasma D-Dimer in Ovarian Cancer: A Meta-Analysis.” Medicine, 96(25), e7062. https://doi.org/10.1097/MD.0000000000007062
Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi-Cover
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2012
  • Yayıncı: -
Sayıdaki Diğer Makaleler

Vajinal Doğum Yapan Annelerin Doğuma İlişkin Travma Algısı İle Maternal Bağlanma Düzeyi Arasındaki İlişkinin İncelenmesi: Bir Kesitsel Çalışma

Ruveyde AYDIN, Songül AKTAŞ, Dilek KALOĞLU BİNİCİ

COVID-19 Pandemi Sürecinde Çocuk İstismarı

Edanur TAR, Betül ÇETİNTAŞ, Derya ATİK

Birinci Basamak Sağlık Hizmetleri Ekiplerinde Hekimler ve Hemşireler Arasındaki İş Birliği Ölçeğinin Türkçeye Uyarlanması: Geçerlik ve Güvenirlik Çalışması

Kürşat YURDAKOŞ, Kutay YÜZÜAK

Pandemi ile Mücadele Eden Sağlık Çalışanlarının COVID-19 Bilgi Düzeyleri ve COVID-19 Tanısı Alma Durumlarını Etkileyen Faktörlerin Belirlenmesi

Ceyda UZUN ŞAHİN, Nurşen KULAKAÇ

Koroner Yoğun Bakımda Hasta Deneyimleri ve Etkileyen Faktörlerin Saptanması

Elanur SARIGÜL, Mehtap KAVURMACI

Assessment of Some Biochemistry Parameters in Hospitalized Patients Evaluated with CT and RT-PCR for The Diagnosis of Covid-19

Ayşegül SÜMER, Lütfiye Nur UZUN

Pandemi Sürecinde Hemşirelik Esasları Uygulama Derslerinin Uzaktan Eğitim ile Yürütülmesi Konusunda Akademisyenlerin Deneyimleri

Özlem ALBAYRAK, Kübra BERBER, Elanur ULUDAĞ

COVID-19 Salgın Döneminde Sağlık Çalışanlarının Algıladıkları Sosyal Destek ile Durumluk Kaygı Düzeyleri Arasındaki İlişkinin Değerlendirilmesi

Betül ÖNAL, Tuğçe ATEŞ, Havva ÖZTÜRK, Zeliha ÇOLAK

Gebe Kalma Şeklinin Çocuklarda Hipospadias Oluşumu Üzerine Etkisinin Belirlenmesi

Solmaz ŞAHİN, Yeliz KAYA

Kanser Sonrası Yaşamın Yönetimi

Yasemin GÜÇLÜEL, Gülbeyaz CAN